Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

A personalized, intense physical rehabilitation program improves walking in people with multiple sclerosis presenting with different levels of disability: a retrospective cohort.
Predictors of disability worsening in clinically isolated syndrome.
The two sides of pseudo-bulbar disorder in multiple sclerosis: Comparing one patient's experience with a review of the neurologic literature.
Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis peptides are cross recognized by anti-myelin basic protein antibodies in multiple sclerosis patients.
Experiences of functional electrical stimulation (FES) and ankle foot orthoses (AFOs) for foot-drop in people with multiple sclerosis.
Immunomodulation by statins: inhibition of cholesterol vs. isoprenoid biosynthesis.
Protective Effect of a cAMP Analogue on Behavioral Deficits and Neuropathological Changes in Cuprizone Model of Demyelination.
Safety and Efficacy Study of MIS416 to Treat Secondary Progressive Multiple Sclerosis
The meninges: new therapeutic targets for multiple sclerosis.
CD226 Gly307Ser Association With Neuromyelitis Optica in Southern Han Chinese.
[Amino acids content in the blood serum of patients with multiple sclerosis.]
Distress associated with patients' symptoms and depression in a sample of Mexican caregivers of individuals with MS.
Color blindness among multiple sclerosis patients in Isfahan.
LSN MS guidelines for the management of multiple sclerosis.
Neurological deficits caused by tissue hypoxia in neuroinflammatory disease.
Paroxysmal ataxia and dysarthria in multiple sclerosis.
Sacral nerve stimulation for neurogenic bladder.
Potassium channel KIR4.1-specific antibodies in children with acquired demyelinating CNS disease.
The impact of the human genome project on complex disease.
Oral fingolimod reduces glutamate-mediated intracortical excitability in relapsing-remitting multiple sclerosis.
What is needed to keep persons with multiple sclerosis vitamin D-sufficient throughout the year?
The earlier, the smaller, the better for natalizumab-associated PML: In MRI vigilance veritas?
Employment as a health promotion intervention for persons with multiple sclerosis.
Statistical estimation of T1 relaxation times using conventional magnetic resonance imaging.
mTOR kinase, a key player in the regulation of glial functions: Relevance for the therapy of multiple sclerosis.

Pages